Cancel
Known information
- Held positions of increasing responsibility over 18 years at Genentech
- Worked across a broad range of therapeutic areas and indications
- Led a translational research department focused on disease mechanisms, biomarker discovery, and reverse translation
- Supported biomarker discovery, biomarker strategy development, and clinical implementation across all phases of drug development
- Contributed to multiple IND filings
- Co-authored over 50 primary research papers and review articles
- Inventor on five patents
- Received a B.Sc. in Biochemistry from Imperial College London
- Received a Ph.D. in Immunology and Molecular Biology from the University of Cambridge
- Carried out postdoctoral research in the laboratory of Laurie Glimcher, M.D., at the Harvard School of Public Health
About TRex Bio
TRex Bio is a biotechnology company that develops treatments for immune-mediated diseases using a human tissue-based platform combined with machine learning and high-throughput '-omics'.
Report inaccurate information
